In This Section

[Presentation #2302] Improving Care for Patients With Stage III/IV NSCLC: Learnings for Thoracic Surgeons and Radiation Oncologists From a National Quality Survey

October 27, 2020

Presented at the ASTRO 2020 Annual Meeting, October 24 to October 28, 2020.


Brendon Stiles1,2, Leigh M. Boehmer3, Percy Lee4

1New York-Presbyterian Hospital, New York, NY, USA; 2Weill Cornell Medical Center, New York, NY, USA; 3Association of Community Cancer Centers, Rockville, MD, USA; 4Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA


Multidisciplinary teams (MDTs) could help optimize quality of care by enhancing patient involvement in decision-making, timely care delivery, accurate staging, and appropriate treatment planning1.

Evolving treatment modalities for stage III and IV non-small cell lung cancer (NSCLC) warrants multidisciplinary collaborations2Thoracic surgeons (TSs), radiation oncologists (ROs), and medical oncologists (MOs) as part of MDTs could play major roles in defining unresectability, diagnosis and treatment planning, and management of patients with inoperable stage III and stage IV NSCLC3,4.

A national survey of multidisciplinary specialists, including TSs, ROs, and MOs, was conducted to obtain insights into care of patients with advanced NSCLC across 160 U.S. community cancer programs.

Audio Presentation


NSCLC Thoracic and radonc infographic thumbnail
Download Infographic


Video Summary


ACCC Buzz Blog Post


ASCO Abstract: What Defines Quality Lung Cancer Care?
June 12, 2020



1. Osarogiagbon RU: Making the Evidentiary Case for Universal Multidisciplinary Thoracic Oncologic Care. Clin Lung Cancer 19:294-300, 2018

2. David EA, Clark JM, Cooke DT, et al: The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung Cancer. J Thorac Oncol 12:1636-1645, 2017

3. National Comprehensive Cancer Network (NCCN) guidelines. 2020. org/professionals/physician_gls/pdf/nscl.pdf. Accessed July 18, 2020.

4. Hait WN, Holland JF, Frei E III, et al: Principles of Medical Oncology, Holland‐Frei Cancer Medicine 1-9, 2017

Our Partners



Our Supporter


This project is made possible by support from AstraZeneca.